Results 141 to 150 of about 4,200 (201)

ACE Inhibitors and ARBs in Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials on Albuminuria Reduction, eGFR Decline, and Safety. [PDF]

Cureus
Avula A, Johal LK, Ali F, Amir S, Yadav S, Murtuza M, Zia U, Janjua FF, Raza A, Lal K, Abid M, Khan R.   +11 more
europepmc   +1 more source

Event rates in major Phase 3 heart failure trials over the last 20 years. [PDF]

ESC Heart Fail
Aimo A, Panichella G, Ripoli A, Mendieta Badimon G, Zannad F, Emdin M.   +5 more
europepmc   +1 more source

Resistant Hypertension: Integration of Novel Agents and Interventional Approaches in Clinical Practice. [PDF]

Rev Cardiovasc Med
Arriola-Montenegro J, Chaponan-Lavalle A, Nombera-Aznaran N, Abdalla M, Bizer B, Mohan A, Muñoz Verdugo IA, Zardoost P, Ordaya-Gonzales K, Villarreal Rizzo A, Rios-Garcia W, Yip LKY, Gonzalez Suarez ML.   +12 more
europepmc   +1 more source

Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point. [PDF]

J Am Soc Nephrol
Jongs N, Gasparyan SB, Frison L, Schloemer P, Brinker M, Little DJ, Heerspink HJL.   +6 more
europepmc   +1 more source

Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global Relevance. [PDF]

J Am Heart Assoc
Yang M, Kondo T, Dewan P, Desai AS, Sibulo AS, Lam CSP, Chiang CE, Gomez EA, Martinez FA, Thierer J, Nicolau JC, Kerr Saraiva JF, Kitakaze M, Packer M, Vaduganathan M, Vinh PN, Abraham WT, Jhund PS, Solomon SD, McMurray JJV.   +19 more
europepmc   +1 more source

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]

BMC Nephrol
Yanagidani H, Maeoka Y, Yoshida M, Ueda M, Kumano M, Takahashi A, Okubo A, Kato N, Maruyama S, Masaki T.   +9 more
europepmc   +1 more source

Successful treatment of severe renal failure caused by malignant hypertension using a combination of renin-angiotensin-aldosterone system inhibitors: a case report. [PDF]

CEN Case Rep
Harada W, Maeoka Y, Takahashi A, Yoshida M, Osaki Y, Ishiuchi N, Sasaki K, Masaki T.   +7 more
europepmc   +1 more source

Amlodipine-Associated Angioedema: An Integrated Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis and Case Reviews. [PDF]

J Clin Med
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

Prediction of metabolism and solubility of tablet-form drugs according to the biopharmaceutical drug disposition classification system. [PDF]

ADMET DMPK
Pushkarova Y, Zaitseva G, Bouaalam K.
europepmc   +1 more source